Skip to content
Open menu Close menu

Dr Duncan Petty

PositionResearch Practitioner in Primary Care Pharmacy
LocationK33, Richmond building
DepartmentSchool of Pharmacy and Medical Sciences
EmailD.R.Petty1@bradford.ac.uk
ORCID0000-0003-2763-0726

Research Interests (key words only)

Polypharmacy, deprescribing, interface prescribing

PhD Supervision

Kristina Medlinskiene, A study of barriers and enablers to the introduction of innovative medicines into patient care.

Teaching and Supervisory Responsibilities

  • Foundations in primary care pharmacy - Module lead
  • Advanced Pharmacy Practice (Primary Care) - course adviser and teacher
  • Clinical Pharmacy (Primary Care) - course adviser and teacher
  • Undergraduate teaching on the MPharm (Hons) courses

Biography

I work part time at the University researching and supporting others, in researching polypharmacy, deprescribing, interface prescribing in primary care practice.

Outside of the University I am Chairman of a company that provides clinical pharmacists into General Practice called Prescribing Support Services Ltd.

Study History

  • Pharmacy degree – Sunderland University 1985
  • Diploma in Clinical Pharmacy – University of Wales Institute of Science and Technology 1989
  • PhD – University of Leeds 2003

Professional History

  • Pre-registration pharmacist - Leeds General Infirmary, 1987
  • Basic Grade Pharmacist – Leeds General Infirmary, 1986
  • Resident Pharmacist Derbyshire Royal Infirmary, 1987 to 1989
  • Pharmacist Leeds General Infirmary (various roles), 1989 to 1997
  • Pharmaceutical Adviser - Leeds Health Authority, 1997 to 1998
  • PhD Student University of Leeds, 1998 to 2003
  • Prescribing Support Services Ltd (CEO), 2000 to present
  • Lecturer Practitioner - University of Leeds, 2001 to 2014
  • Fellow of the Royal Pharmaceutical Society, 2017

Professional Activities

Honorary Research Clinical Pharmacist, University of Leeds, Leeds Institute of Health Sciences. 2016 to present

Current Projects

  • University of Bradford. Improving the safe use of medicines in older patients with frailty through deprescribing
  • University of Bradford. Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT)
  • Leeds Institute of Health Sciences. Action to Support Practices to Research Evidence (ASPIRE)
  • Leeds Institute of Health Sciences. Developing and feasibility testing an Acceptance and Commitment Therapy (ACT) interventION for improving medication-taking behaviour in women with early stage invasive breast cancer: The ACTION trial.

Research Collaborations

  • Leeds Institute of Health Sciences. Action to Support Practices to Research Evidence (ASPIRE)
  • Leeds Institute of Health Sciences. Developing and feasibility testing an Acceptance and Commitment Therapy (ACT) interventION for improving medication-taking behaviour in women with early stage invasive breast cancer: The ACTION trial.

Publications

See Dr Petty's publications on Bradford Scholars.

  • Marques I., Petty D., Raynor T, Blenkinsopp A. Deprescribing models: review of the evidence (2017), Prescribing and Research in Medicines Management (UK & Ireland) Annual Conference 2017, University of Coventry London Campus, January 28th 2017: “Deprescribing - is less more?”. Pharmacoepidemiol Drug Saf, 26: 3–20. doi:10.1002/pds.4221
  • Marques I., Petty D., Raynor T., Blenkinsopp A. Reducing inappropriate polypharmacy through a patient-centred, shared decision-making model of deprescribing. (2017), Prescribing and Research in Medicines Management (UK & Ireland) Annual Conference 2017, University of Coventry London Campus, January 28th 2017: “Deprescribing - is less more?”. Pharmacoepidemiol Drug Saf, 26: 3–20. doi:10.1002/pds.4221
  • Glidewell L, Willis T, Petty D et al on behalf of the ASPIRE programme team. To what extent can Behaviour Change Techniques be embedded within an adaptable implementation package for primary care? A directed content analysis. Submitted to Implementation Science 2017
  • Ziegler L, Mulvey M, Blenkinsopp A, Petty D, Bennett MI. Opioid prescribing for patients with cancer in the last year of life: a longitudinal population cohort study. Pain. 2016. August 2016: ISSN 0304-3959
  • Foy R, Leaman B, McCrorie C, Petty D, House A, Bennett M, Carder P, Faulkner S, Glidewell L, West R. Prescribing opioids in primary care: cross-sectional and longitudinal analyses of influences of patient and practice characteristics. BMJ Open May 13;6(5):e010276. doi: 10.1136/bmjopen-2015-010276
  • McCrorie C, Closs J, House A, Petty D, Zeigler L, Glidewell L, West R, Foy R. Understanding long-term prescribing for non-cancer pain in primary care: a qualitative study. BMC Family Practice 2015;16:121.
  • Assessing kidney function in oral anticoagulant prescribing: an aid for safer drug and dose choices. Wood S, Petty D, Fay M and Lewington A.: Br J Cardiol 2013;20:61–4
  • Wood S, Petty D, Glidewell L, Raynor T. Are we over-dosing our elderly patients with renally excreted drugs in primary care? IJPP 2011;19 (suppl. 2):38
  • The Scale of Repeat Prescribing- time for an update Petty DR, Zermansky AG, Alldred DP. BNC Health Service Research. http://www.biomedcentral.com/1472-6963/14/76

In the News/Media

Repeat Prescribing Report. November 2017 - interviews on national and local media.

Share this

Upcoming events

View all events »